Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

All wines have some volatile acidity, which can add to a wine’s complexity at low levels. At what point does it become a ...

Schlegel's academic journey later brought him to two of the world's most respected institutions for technological research: ...

Dark oxygen, a newly identified form of oxygen, raises questions about life in extreme environments and its implications for ...

Women with hypertension who followed a very low-calorie ketogenic diet had greater reductions in systolic and diastolic blood ...

Silver Storm Mining Ltd. (“Silver Storm” or the "Company") (TSX.V: SVRS | OTC: SVRSF | FSE: SVR), is pleased to announce the results of an updated Mineral Resource estimate (“Updated Mineral Resource ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...

Researchers make use of small-angle X-ray scattering to reveal potential-dependent structural changes in redox enzymes used ...

Chlorite, chlorate, and the carcinogenic bromate are by-products that are formed during the disinfection process. Their determination in the presence of the standard anions is regulated by various ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...